RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE

RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE

Show other versions (1)

<p>The clinical, cell and genetic factors are distinguished among reasons for resistance to antiplatelet drugs. There are many methods to detect sensitivity to antiplatelet drugs, but they all have disadvantages. Moreover, there is no unified approach for interpretation of received results, an...

Full description

Bibliographic Details
Main Authors: D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
антитромбоцитарные препараты
клопидогрель
резистентность к ацетилсалициловой кислоте
Online Access:http://www.rpcardio.ru/jour/article/view/458
id doaj-d5d2fddeffa0452cae110c7f74569a65
record_format Article
spelling doaj-d5d2fddeffa0452cae110c7f74569a652020-11-25T00:19:22ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-12-0133525910.1234/1819-6446-2007-3-52-59458RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASED. H. Aynetdinova0A. E. Udovichenko1V. A. Sulimov2Московская медицинская академия им. И. М. СеченоваМосковская медицинская академия им. И. М. СеченоваМосковская медицинская академия им. И. М. Сеченова<p>The clinical, cell and genetic factors are distinguished among reasons for resistance to antiplatelet drugs. There are many methods to detect sensitivity to antiplatelet drugs, but they all have disadvantages. Moreover, there is no unified approach for interpretation of received results, and no recommendations for their practical use. It is necessary to work out unified procedure to assess platelet function, to define indications for its usage and to work out unified criteria of resistance. Individualized approach and each patient’s peculiarities consideration are essential when prescribing antiplatelet therapy.</p>http://www.rpcardio.ru/jour/article/view/458антитромбоцитарные препаратыклопидогрельрезистентность к ацетилсалициловой кислоте
collection DOAJ
language English
format Article
sources DOAJ
author D. H. Aynetdinova
A. E. Udovichenko
V. A. Sulimov
spellingShingle D. H. Aynetdinova
A. E. Udovichenko
V. A. Sulimov
RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
Racionalʹnaâ Farmakoterapiâ v Kardiologii
антитромбоцитарные препараты
клопидогрель
резистентность к ацетилсалициловой кислоте
author_facet D. H. Aynetdinova
A. E. Udovichenko
V. A. Sulimov
author_sort D. H. Aynetdinova
title RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_short RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_full RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_fullStr RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_full_unstemmed RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
title_sort resistance to antiplatelet drugs in patients with ischemic heart disease
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2015-12-01
description <p>The clinical, cell and genetic factors are distinguished among reasons for resistance to antiplatelet drugs. There are many methods to detect sensitivity to antiplatelet drugs, but they all have disadvantages. Moreover, there is no unified approach for interpretation of received results, and no recommendations for their practical use. It is necessary to work out unified procedure to assess platelet function, to define indications for its usage and to work out unified criteria of resistance. Individualized approach and each patient’s peculiarities consideration are essential when prescribing antiplatelet therapy.</p>
topic антитромбоцитарные препараты
клопидогрель
резистентность к ацетилсалициловой кислоте
url http://www.rpcardio.ru/jour/article/view/458
work_keys_str_mv AT dhaynetdinova resistancetoantiplateletdrugsinpatientswithischemicheartdisease
AT aeudovichenko resistancetoantiplateletdrugsinpatientswithischemicheartdisease
AT vasulimov resistancetoantiplateletdrugsinpatientswithischemicheartdisease
_version_ 1725371763756367872

Similar Items